Evidence map›Paper›PMID 34163067›Full record

Trial reportNature2021

Caloric restriction disrupts the microbiota and colonization resistance.

Reiner Jumpertz von Schwartzenberg, Jordan E Bisanz, Svetlana Lyalina, Peter Spanogiannopoulos, Qi Yan Ang, Jingwei Cai, Sophia Dickmann, Marie Friedrich, Su-Yang Liu, Stephanie L Collins and 8 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed, 2 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 2 syntheses or guidelines pooled it, 206 citations in OpenAlex.

  1. Roles of the gut microbiome in weight management.Nature reviews. Microbiology · 2023
    Pooled it
  2. Pooled it
  3. Trial
  4. Testosterone administration partially modulates gut microbiota responses to severe energy deficit.American journal of physiology. Endocrinology and metabolism · 2026
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 2 countries.

Reiner Jumpertz von Schwartzenberg *Charité Universitätsmedizin Berlin, Department of Endocrinology and Metabolic Diseases, Berlin, Germany.
Jordan E Bisanz *Department of Microbiology & Immunology, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-8649-1706
Svetlana LyalinaGladstone Institutes, San Francisco, CA, USA.
Peter SpanogiannopoulosDepartment of Microbiology & Immunology, University of California San Francisco, San Francisco, CA, USA.
Qi Yan AngDepartment of Microbiology & Immunology, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-9788-1283
Jingwei CaiCenter for Molecular Toxicology and Carcinogenesis, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, USA.
Sophia DickmannCharité Universitätsmedizin Berlin, Department of Endocrinology and Metabolic Diseases, Berlin, Germany.
Marie FriedrichCharité Universitätsmedizin Berlin, Department of Endocrinology and Metabolic Diseases, Berlin, Germany.
Su-Yang LiuDepartment of Pathology, University of California San Francisco, San Francisco, CA, USA.
Stephanie L CollinsCenter for Molecular Toxicology and Carcinogenesis, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, USA.
Danielle IngebrigtsenDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Steve MillerDepartment of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
Jessie A TurnbaughDepartment of Microbiology & Immunology, University of California San Francisco, San Francisco, CA, USA.
Andrew D PattersonCenter for Molecular Toxicology and Carcinogenesis, Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, USA.ORCID http://orcid.org/0000-0003-2073-0070
Katherine S PollardGladstone Institutes, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-9870-6196
Knut MaiCharité Universitätsmedizin Berlin, Department of Endocrinology and Metabolic Diseases, Berlin, Germany.
Joachim SprangerCharité Universitätsmedizin Berlin, Department of Endocrinology and Metabolic Diseases, Berlin, Germany. joachim.spranger@charite.de.ORCID http://orcid.org/0000-0002-8900-4467
Peter J TurnbaughDepartment of Microbiology & Immunology, University of California San Francisco, San Francisco, CA, USA. peter.turnbaugh@ucsf.edu.ORCID http://orcid.org/0000-0002-0888-2875
University of California, San Francisco · USPennsylvania State University · USCharité - Universitätsmedizin Berlin · DEGerman Centre for Cardiovascular Research · DEGladstone Institutes · USBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DE

Funding

UCSF Nutrition Obesity Research CenterP30DK098722 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHRISTIAN VAISSE · 2015 to 2026
$14.6M
Predicting and preventing drug metabolism by the human gut microbiomeR01HL122593 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Peter James Turnbaugh · 2016 to 2026
$5.7M
Employing the gut microbiome to accelerate effective initiation of rheumatoid arthritis therapyR01AR074500 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Renuka Rajendra Nayak, Jose U. Scher · 2019 to 2026
$4.1M
Host-microbiome interactions shape the metabolic effects of ketogenic dietsR01DK114034 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI TURNBAUGH, PETER JAMES · 2020 to 2024
$2.5M
Diet-microbe interactions modulating host energy balanceR00AI147165 · NIAID · PENNSYLVANIA STATE UNIVERSITY, THE · PI BISANZ, JORDAN ADAM · 2021 to 2022
$498k
(PQ10) Harnessing the human gut microbiome to predict chemotherapy outcomesR21CA227232 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ATREYA, CHLOE E., TURNBAUGH, PETER JAMES · 2018 to 2019
$378k
Diet-microbe interactions modulating host energy balanceK99AI147165 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BISANZ, JORDAN ADAM · 2020 to 2020
$136k
NCI NIH HHS R21 CA227232NHLBI NIH HHS R01 HL122593NIAID NIH HHS K99 AI147165NIAID NIH HHS R00 AI147165NIAMS NIH HHS R01 AR074500NIDDK NIH HHS P30 DK098722NIDDK NIH HHS R01 DK114034NIH HHS 1R01 AR074500NIH HHS 1R01 DK114034
6 · The paper itself

Abstract

Diet is a major factor that shapes the gut microbiome

Indexed as

Caloric RestrictionDiet, ReducingAdiposityAnimalsBacteriaBacterial ToxinsBile Acids and SaltsBody WeightClostridioides difficileEnergy MetabolismGastrointestinal MicrobiomeHumansIntestinal AbsorptionMaleMiceNutrientsBacterial ToxinsBile Acids and SaltsNutrients

Identifiers

PMID34163067
PMCPMC8959578
OpenAlexW3177080894

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.